Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
1 MOVEMENT DISORDERS Disorders of movement form a substantial part of neurodegenerative diseases. They divide broadly into 1-akinetic-rigid syndromes; slowed movement with increased tone (also called parkinsonism), 2-dyskinesias - added, uncontrollable movements. Parkinsonism Is a clinical syndrome characterised by bradykinesia with associated increased tone [ rigidity] , tremor and loss of postural reflexes 1-Idiopathic Parkinson’s disease [ 80%] 2-Drug and toxin [antipsychotic drug, tetrabenzin and MPTP] 3-Other neurodegenerative disease [dementia with Lewy bodies, progressive supranuclear palsy] 4-Genetic [Huntington’s disease, Wilson’disease and fragile X syndrome] 5-Anoxic brain injury 6-cerebrovascular accident Dyskinesias Essential tremor Chorea Hemiballismus Myoclonus Tic or 'habit spasms 'Torsion dystonias Paroxysmal dyskinesias AKINETIC-RIGID SYNDROMES (Idiopathic Parkinson's disease ) 1817, James Parkinson, a physician in Hoxton, London, published The Shaking Palsy, describing this common world-wide condition, with prevalence of 150/100 000 increasing sharply in those over 70 years. Parkinson's disease is clinically and pathologically distinct from other parkinsonian syndromes. There are few real clues as to the cause of idiopathic Parkinson's disease (PD). The relatively uniform worldwide prevalence suggests that an environmental agent is not responsible. Some factors possibly involved are : *Nicotine. Several epidemiological studies confirm the curious fact that PD is less prevalent in tobacco smokers than in lifelong abstainers. * MPTP. Minute doses of the pyridine compound, methylphenyltetrahydropyridine (MPTP) cause severe parkinsonism. *Encephalitis lethargica. Some survivors of the epidemic, presumed viral encephalitis lethargica, developed severe parkinsonism. 2 *Genetic factors. Whilst not usually familial, there is clustering of early-onset Parkinson's disease in some family Pathology : In the pars compacta of the substantia nigra, progressive cell degeneration and neuronal eosinophilic inclusion bodies (Lewy bodies) are seen [alpha-sunclein protein].. Degeneration also occurs in other basal ganglia nuclei. Biochemically there is loss of dopamine (and melanin) in the striatum. This correlates well with cell loss and with the degree of akinesia Clinical symptoms The combination of tremor, rigidity and akinesia develops slowly, over months or several years, together with changes in posture. The most common initial symptoms are tremor and slowness. Patients complain that limbs and joints feel stiff. They ache. Fine movements become difficult. Slowness causes characteristic difficulty rising from a chair or getting into or out of bed. Writing becomes small (micrographia) and spidery, and tends to tail off. Relatives often notice other features - slowness and an impassive face. Idiopathic PD is almost always initially more prominent on one side. Clinical signs Diagnosis is usually evident from the overall appearance ** Tremor The characteristic 4-7 Hz pill-rolling (movements between thumb and finger) rest tremor usually decreases with action. Tremor is often asymptomatic at first. ** Rigidity Stiffness develops throughout the range of limb movement and. This 'lead pipe' increase in tone is usually more marked on one side. It is also present in the neck and axial muscles. This plastic rigidity is more easily felt when a joint is moved slowly and gently. When one arm is being examined, its tone increases when the opposite arm moves actively. When stiffness occurs with tremor, smooth 'lead-pipe' rigidity is broken up into a jerky resistance to passive movement - known as cogwheeling, or cogging Akinesia Poverty and slowing of movement (bradykinesia) is an additional handicap, distinct from rigidity. There is difficulty initiating movement. Rapid fine finger movements, such as piano-playing, become indistinct, slow and tremulous. Facial immobility gives a mask-like semblance of depression. The frequency of spontaneous blinking is reduced, producing a 'serpentine' stare. ** Postural changes A stoop is characteristic. Gait becomes, hurrying (festinant) and shuffling with poor arm swinging. Balance deteriorates, but despite this the gait retains a narrow base. Falls are common in later stages of PD. ** Speech Pronunciation is initially a monotone but progresses to characteristic tremulous slurring dysarthria, the result of combined akinesia, tremor and rigidity. Speech may eventually be lost completely (anarthria). 3 ** Gastrointestinal and other symptoms These include heartburn, dribbling, dysphagia, constipation and weight loss. Urinary difficulties are common, especially in men. Skin is greasy and sweating excessive. Non-motor aspects of PD include depression and anxiety, cognitive impairment, sleep disturbances, sensory abnormalities and pain, loss of smell (anosmia), and disturbances of autonomic function. Together these may contribute as much to the burden of the disease as the more obvious motor abnormalities. Some of these nonmotor disturbances may be present long before the onset of motor signs. The physiologic basis of the non-motor signs and symptoms are explained in part by widespread involvement of brainstem, olfactory, thalamic, and cortical structures Natural history and other features Parkinson's disease worsens over some years, beginning as a mild inconvenience but slowly progressing. While bradykinesia and tremor worsen, power remains normal until immobility makes its assessment difficult. Patients often complain of limb and joint discomfort. There is no sensory loss. The reflexes are brisk; their asymmetry follows the increase in tone. The plantar responses remain flexor. Cognitive function is preserved, at least early on. Dementia often develops in the late stages. Anxiety and depression are common. The rate of progression is very variable, with a benign form running over several decades. Usually the course is over 10-15 years, with death resulting from bronchopneumonia Diagnosis There is no laboratory test - the diagnosis is made by recognizing physical signs and distinguishing idiopathic PD from other parkinsonian syndromes. Conventional imaging (MR) is normal. Dopamine transporter imaging (available in some specialist centres) discriminates poorly - both between normal and pathological and between PD and other akinetic-rigid syndromes. Other diffuse and multifocal brain diseases can cause features of parkinsonism, i.e. the slowing, rigidity and tremor seen in idiopathic PD. Examples are Alzheimer's disease, multi-infarct dementia, sequelae of repeated head injury (e.g. in boxers, and the late effects of severe hypoxia or carbon monoxide poisoning. Slowing also occurs in hypothyroidism, and in depression. Treatment While no drugs alter the course of Parkinson's disease, levodopa and/or dopaminergic agonists produce striking initial symptomatic improvement. These drugs should be avoided until they are clinically necessary because of delayed unwanted effects (). Catechol-O-methyl transferase inhibitors are also used as supplementary therapy. Older treatments such as the antimuscarinic trihexyphenidyl (benzhexol) helped little and frequently caused confusion; they are of some value in severe tremor. Selegeline, a monoamine oxidase B inhibitor, may 4 delay the need for levodopa therapy by some months. Antioxidants are also used with this aim, but their value is unproven Levodopa Levodopa is combined with an aromatic amino acid decarboxylase inhibitor benserazide (co-beneldopa, as Madopar) or carbidopa (co-careldopa, as Sinemet). The decarboxylase inhibitor reduces peripheral side-effects, principally nausea, of levodopa and its metabolites. Levodopa treatment is commenced (co-beneldopa 62.5 mg or co-careldopa 110 mg, one tablet three times daily) and gradually increased The great majority of patients with idiopathic PD (but not other parkinsonian syndromes) improve initially with levodopa. The response in severe, previously untreated idiopathic PD is sometimes dramatic. ** Unwanted effects of levodopa therapy Nausea and vomiting are the most common immediate symptoms of excess levodopa. Confusion, formed visual pseudo-hallucinations and chorea also occur. There are difficult issues with long-term therapy (e.g. levodopa-induced involuntary movements). After several years levodopa gradually becomes ineffective, even with increasing doses. As treatment continues, episodes of immobility develop (freezing). Falls are common. Fluctuation in response to levodopa also appears, its effect apparently turning on and off, causing freezing alternating with dopa-induced dyskinesias, chorea and dystonic movements. Approaches to treatment of these complications include: Shortening the interval between levodopa doses and increasing each dose. Selegiline, a type B monoamine oxidase inhibitor, inhibits catabolism of dopamine in the brain. Dopaminergic agonists are added, or replace levodopa. Entacapone (a catechol-O-methyl transferase inhibitor) is used. Drug holidays - periods of drug withdrawal - are occasionally helpful. They require close supervision since severe relapse may follow levodopa withdrawal. Dopamine receptor agonists Bromocriptine, lisuride, pergolide, cabergoline (ergot derivatives), pramipexole and ropinirole are oral directly acting dopamine receptor agonists, acting principally on D1 and D2 receptors, and also on receptors D3-5. These are used as an alternative or an addition to levodopa therapy. The ergot derivatives are associated with pulmonary, retroperitoneal and pericardial fibrotic reactions. 5 Other agents Antioxidant compounds such as vitamins C and E (possible neuroprotective agents) are sometimes suggested. Their role is uncertain. Amantadine, originally marketed as an antiviral drug, occasionally has a modest effect.. Stereotactic neurosurgery Stereotactic lesions, usually unilateral in the ventrolateral nucleus of the thalamus (thalamotomy) or in the globus pallidus (pallidotomy), were used widely before levodopa. Surgery still provides effective, if temporary improvement in tremor and dyskinesia with minor relief of bradykinesia. Thalamic stimulation is also used. There has been a revival of interest in surgery in the last decade. Tissue transplantation Despite early promise and suggestive laboratory studies in rats with MPTP-induced parkinsonism, tissue transplantation is little used. Experimental transplantation of fetal or autologous dopamine-containing adrenal medulla and glial cell-line neurotrophic releasing factor (GDNF) into the cerebral ventricles or basal ganglia, does not produce any sustained improvement. Physiotherapy and physical aids Skilled and determined therapy can improve gait and help overcome particular problems. Practical guidance is of value: Psychiatric aspects Depression is common as PD progresses. Selective serotonin reuptake inhibitors (SSRIs) are the drugs of choice. Tricyclic antidepressants (e.g. amitriptyline) have extrapyramidal side-effects. Type A monoamine oxidase inhibitors (e.g. phenelzine) are absolutely contraindicated with levodopa. All antiparkinsonian drugs can cause visual hallucinations, especially at night, and exacerbate cognitive impairment. OTHER AKINETIC-RIGID SYNDROMES ( Drug-induced parkinsonism ) Reserpine and methyldopa (drugs once used to treat hypertension), phenothiazines and butyrophenones induce parkinsonism, with slowness and rigidity but usually little tremor. Tricyclic antidepressants also cause some slowing. These unwanted effects tend not to progress and settle when a drug is stopped. They respond negligibly to levodopa. Acute dystonic reactions. These occur (dramatically and unpredictably) after single doses of neuroleptics and related drugs widely used as antiemetics and vestibular sedatives (e.g. metoclopramide and prochlorperazine). Spasmodic torticollis, trismus and oculogyric crises (i.e. episodes of sustained upward gaze) occur. These acute dystonias respond promptly to i.v. antimuscarinics, e.g. benzatropine (1-2 mg) or procyclidine 5-10 mg. The offending drug (and all similar) should be avoided forever Chronic tardive dyskinesias. These are mouthing and lip-smacking grimaces, disabling disorders that occur several years after commencing neuroleptics. They 6 often become temporarily worse when the neuroleptic dose is reduced. Resolution seldom occurs, even if treatment ceases. Post-encephalitic parkinsonism and MPTP (Parkinsonism-plus) This describes rare disorders in which there is parkinsonism with additional features and pathology. Progressive supranuclear palsy (Steele-Richardson-Olzewski syndrome) is the commonest. It consists of parkinsonism, axial rigidity, falls, dementia, and inability to move the eyes vertically or laterally. Other examples are multiple system atrophies, such as olivo-ponto-cerebellar degeneration and primary autonomic failure (Shy-Drager syndrome). These are progressive, unresponsive to levodopa and usually cause death within a decade DYSKINESIAS *Benign essential tremor This common condition, often inherited as an autosomal dominant trait, causes 5-8 Hz tremor, usually worse in the upper limbs. The head is often tremulous (titubation) and also the trunk. Pathologically there is patchy neuronal loss in the cerebellum and its connections. Tremor develops when the hands adopt a posture, such as holding a glass or a spoon. Essential tremor occurs at any age but occurs most frequently in the elderly. It is slowly progressive but rarely produces severe disability. Treatment is often unnecessary, and unsatisfactory. Many patients are reassured to find they do not have Parkinson's disease, with which essential tremor is often confused. Small amounts of alcohol, β-adrenergic blockers (propranolol) and the anticonvulsant primidone may help the tremor: sympathomimetics (e.g. salbutamol) make it worse. The antidepressant mirtazapine has some effect. Stereotactic thalamotomy and thalamic stimulation are used in severe cases. *Chorea Chorea means jerky, quasi-purposive, explosive, fidgety movements, flitting around the body -. Causes of chorea Huntington's disease , Sydenham's chorea ,Benign hereditary chorea ,(Abeta lipoproteinaemia) with chorea ** Chorea associated with Drugs - phenytoin, levodopa, alcohol Thyrotoxicosis, pregnancy and oral contraceptive pill . ** Systemic lupus erythematosus , Polycythaemia vera ,Encephalitis lethargica Stroke (basal ganglia) Rarities , Wilson's disease 7 Huntington's disease : Relentlessly progressive chorea and dementia, usually in middle life but sometimes in childhood, are hallmarks of this inherited disease. Prevalence world-wide is about 5 in 100 000. Inheritance is as an autosomal dominant trait with full penetrance: children of an affected parent have a 50% chance of developing Huntington's disease Sydenham's chorea (St Vitus's dance) This transient postinfective chorea occurs largely in children and young adults. Streptococcal infection is one cause: under half the cases follow within 3 months of rheumatic fever (). The onset is gradual over a few weeks. Irritability, emotional lability, and inattentiveness herald fidgetiness, sometimes mainly unilateral. A minority of patients become confused. Rheumatic heart disease is sometimes found. Fever is unusual. Antistreptolysin-O (ASO) titre and ESR are typically normal. Sedation may be needed. Recovery occurs spontaneously within weeks or months. Phenoxymethylpenicillin should continue to the age of 20 to prevent rheumatic heart disease. Hemiballismus Hemiballismus (also called hemiballism) describes violent swinging movements of one side caused usually by infarction or haemorrhage in the contralateral subthalamic nucleus Torsion dystonias Dystonia means movement caused by prolonged muscular contraction - part of the body is thrown into spasm Primary torsion dystonia (dystonia musculorum deformans) Dystonia affecting gait and posture in childhood progresses, spreading to all parts of the body over one to four decades. Cognitive function is not impaired. Spontaneous remissions occur occasionally. This rare disease is usually inherited as an autosomal dominant. Spasmodic torticollis Dystonic spasms gradually develop around the neck, usually in the third to fifth decade. These cause the head to turn (torticollis) or to be drawn backwards (retrocollis) or forwards (antecollis). Minor dystonic movements often also affect the trunk and limbs. A curious feature in some patients is a single trigger area, often on the jaw. A gentle touch with a finger tip at this specific site relieves the spasm temporarily. Torticollis may remit but often persists indefinitely. Similar features are sometimes seen when no organic disease is present Writer's cramp : This is a specific inability to perform a previously highly developed repetitive skilled movement, e.g. writing. The movement provokes dystonic posturing. Writer's cramp occurs in those who spend many hours each day writing, 8 and is thus seen less frequently than in years past. Other functions of the hand remain normal. There are no other neurological signs. Prolonged rest sometimes helps but the dystonia can cause substantial disability. Similar dystonias occur in other occupations. Treatment All dystonic movement disorders are particularly difficult to help. Butyrophenones (e.g. haloperidol and sulpiride) and antimuscarinics (e.g. trihexyphenidyl (benzhexol)) are sometimes helpful. Botulinum toxin carefully sited by injection can help, temporarily, blepharospasm, torticollis and writer's cramp. Neurosurgical treatment, principally stereotactic thalamotomy for torticollis, or neurostimulation brings some temporary alleviation in selected cases.